Medroxyprogesterone Acetate Side Effects and Management
Introduction to Side Effects
- Weight gain at 6 months is a strong predictor of future excessive weight gain with ongoing DMPA use 1
- DMPA causes reductions in bone mineral density (BMD) 1
- The FDA has issued a black-box warning about the risk of decreased BMD among DMPA users 1
- Substantial recovery of BMD occurs after discontinuation of DMPA 1
- Calcium intake (1300 mg daily) and vitamin D (600 IU daily) supplementation are recommended for all patients on DMPA 1
Cardiovascular and Bone Health Risks
- Women using DMPA should be monitored for signs of thromboembolism 2
- ACOG does not advise limiting DMPA use to 2 years, recognizing the risk of unwanted pregnancy if contraceptive options are limited 1
Special Considerations
- When used in transgender care, progestins like medroxyprogesterone acetate can suppress testosterone levels via central feedback 3
- Not recommended by the Endocrine Society for transgender care due to risk of breast cancer, thromboembolism, and stroke 3
- Medroxyprogesterone acetate suppresses circulating androgen levels and pituitary gonadotropin levels in women with PCOS 4
- Can be used to prevent endometrial cancer in women with PCOS, though optimal dosing and frequency are not established 4
Management of Side Effects
- Counseling before initiation about expected menstrual changes improves continuation rates 1
- Regular monitoring of weight and discussing lifestyle modifications may help manage weight gain 1
- Consider alternative contraceptive methods if significant weight gain occurs within first 6 months 1
- Regular weight-bearing exercise is recommended 1
- Calcium (1300 mg daily) and vitamin D (600 IU daily) supplementation 1
Clinical Recommendations
- Thorough pre-treatment counseling about potential side effects significantly improves continuation rates 1
- Schedule follow-up visits every 11-12 weeks for adolescents (rather than every 13 weeks) to allow for missed or delayed visits 1
- Failing to counsel patients about expected menstrual changes before initiating DMPA 1
- Not monitoring weight changes, especially during the first 6 months of use 1
- Overlooking the importance of calcium and vitamin D supplementation for bone health 1